On-Demand

Expanding the Benefits and Refining the Role of Immune Checkpoint Inhibitors in the Treatment of Recurrent and Advanced Endometrial Cancer

Available: April 27, 2022 —
April 26, 2023

Credit: 0.50hr(s)
Credit Types: ABIM, CME, MOC, NCPD

Therapeutic Areas: Endometrial Cancer, Gynecology, Oncology
Specialties: Endometrial Cancer, Gynecologic Cancer, Oncology
Location: Internet Enduring Activity

Course Description

In this activity, an expert in oncology discusses the role of immune checkpoint inhibitors in the care of patients with recurrent and advanced endometrial cancer.

Other Courses in this Series

Other Courses That May be of Interest

Applying Evidence to Practice in Postpartum Depression: Expert Guidance on Integrating Therapeutic Innovations and Shared Decision-Making Strategies to Optimize Patient Care

Expires: April 7, 2023

Credit: 1.00hr(s)
CME

Therapeutic Areas: Gynecology, Women's Health

Carrying Through in Advanced/Metastatic Urothelial Carcinoma: Expert Perspectives on Recent Practice‐Changing Data and the Practicalities of Individualizing and Continuing Care With Novel Immunotherapy Maintenance Strategies

Expires: December 28, 2022

Credit: 1.00hr(s)
CME

Therapeutic Areas: Oncology, Urologic oncology
Specialties: urothelial carcinoma (UC)

Series: CLL/SLL

Episode 1 of 3 - What You MUST Know About the Emerging Standard of Care for 1L Treatment of CLL and SLL

Expires: December 14, 2023

Credit: 0.30hr(s)
AAPA, CME, CPE, NCPD

Therapeutic Areas: Hematologic Oncology, Oncology
Specialties: Chronic Lymphocytic Leukemia (CLL), Small lymphocytic lymphoma (SLL)

Series: NSCLC

Episode 1 of 4 - The Evolution of Biomarker Testing: Revolutionizing Treatment of NSCLC

Expires: November 28, 2023

Credit: 0.30hr(s)
NCPD

Therapeutic Areas: Hematologic Oncology, Oncology
Specialties: Biomarkers, NSCLC

Series: CLL/SLL

CLL-SLL/MTT Episode 2 of 3 - Moving Towards Fixed-Duration Therapy in CLL and SLL

Expires: December 14, 2023

Credit: 0.30hr(s)
AAPA, CME, CPE, NCPD

Therapeutic Areas: Hematologic Oncology, Oncology
Specialties: Chronic Lymphocytic Leukemia (CLL), Small lymphocytic lymphoma (SLL)

Series: NSCLC

Episode 2 of 4 - Biomarker Testing: Shaping Personalized Medicine

Expires: November 28, 2023

Credit: 0.15hr(s)
NCPD

Therapeutic Areas: Hematologic Oncology, Oncology
Specialties: Biomarkers, NSCLC

Series: CLL/SLL

Episode 3 of 3 - Help Your Patients Navigate Risk-benefit Assessment, Choose the Best Therapy for Them, and Mitigate TEAEs

Expires: December 14, 2023

Credit: 0.30hr(s)
AAPA, CME, CPE, NCPD

Therapeutic Areas: Hematologic Oncology, Oncology
Specialties: Chronic Lymphocytic Leukemia (CLL), Small lymphocytic lymphoma (SLL)

Series: NSCLC

Episode 3 of 4 - Novel Therapeutics: Changing the Treatment Landscape for NSCLC

Expires: November 28, 2023

Credit: 0.15hr(s)
NCPD

Therapeutic Areas: Hematologic Oncology, Oncology
Specialties: Biomarkers, NSCLC